Internal Medicine, Hematology & Oncology · Philadelphia, PA
NPI
1811994866
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
51 N 39th St
Philadelphia, PA, 19104
Phone (856) 906-6273
Groups this clinician bills Medicare through
Medicare paid, 2024
$856K
51,708 services
Medicare patients, 2024
559
Average age 75
Drug cost, 2024
$2.1M
475 prescriptions
Company payments, 2025
$213
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Carlos S Madamba was code J1437 (injection, ferric derisomaltose, 10 mg), 2,100 times for 17 patients. In total Carlos S Madamba billed 51,708 services in 88 codes, and Medicare paid $856K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-09-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 2,100 | 17 | $15.88 | $33K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 776 | 332 | $13.06 | $10K |
| 99214 Office E&M - Established | Office | 509 | 272 | $94.15 | $48K |
| 99215 Office E&M - Established | Office | 371 | 168 | $142.83 | $53K |
| 36415 Venipuncture Blood Collection | Office | 255 | 119 | $8.65 | $2,206 |
| 85025 Blood Count | Office | 200 | 105 | $7.61 | $1,522 |
| 99232 Hospital E&M - Subsequent | Facility | 106 | 66 | $64.47 | $6,834 |
| 96409 Chemotherapy Administration | Office | 100 | 12 | $85.89 | $8,589 |
| 96413 Chemotherapy Administration | Office | 86 | 39 | $111.01 | $9,547 |
| 96372 Injection Administration | Office | 80 | 27 | $11.78 | $942 |
| 99223 Hospital E&M - Initial | Facility | 70 | 68 | $141.78 | $9,925 |
| 99205 Office E&M - New | Office | 57 | 57 | $167.37 | $9,540 |
| 85007 Blood Count | Office | 55 | 28 | $3.72 | $205 |
| 85027 Blood Count | Office | 55 | 28 | $6.34 | $349 |
| 96415 Chemotherapy Administration | Office | 47 | 19 | $23.52 | $1,106 |
By year: 2022 $1.4M for 90,980 services; 2023 $1.2M for 57,014 services; 2024 $856K for 51,708 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 255 | 119 | $8.65 | $2,206 |
| 85025 Blood Count | 200 | 105 | $7.61 | $1,522 |
| 85007 Blood Count | 55 | 28 | $3.72 | $205 |
| 85027 Blood Count | 55 | 28 | $6.34 | $349 |
Medicare prescription drug claims, 2024
In 2024, the drug Carlos S Madamba prescribed most often to Medicare patients was Eliquis (Apixaban), with 45 prescriptions and refills. In total Carlos S Madamba wrote 475 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 45 | 68 | Under 11 | $38K |
| Hydroxyurea Generic | 37 | 84 | 11 | $1,041 |
| Imatinib Mesylate Generic | 31 | 31 | Under 11 | $25K |
| Potassium Chloride Generic | 23 | 41 | Under 11 | $442 |
| Imbruvica Ibrutinib | 20 | 20 | Under 11 | $282K |
| Revlimid Lenalidomide | 19 | 19 | Under 11 | $332K |
| Calquence Acalabrutinib Maleate | 18 | 18 | Under 11 | $189K |
| Tavalisse Fostamatinib Disodium | 17 | 17 | Under 11 | $241K |
| Furosemide Generic | 15 | 15 | Under 11 | $50.29 |
| Acyclovir Generic | 15 | 23 | Under 11 | $113 |
| Erleada Apalutamide | 14 | 14 | Under 11 | $204K |
| Lidocaine Hcl Viscous Lidocaine Hcl | 13 | 13 | Under 11 | $119 |
| Gabapentin Generic | 13 | 15 | Under 11 | $138 |
| Levofloxacin Generic | 13 | 13 | Under 11 | $0 |
| Doptelet Avatrombopag Maleate | 12 | 12 | Under 11 | $151K |
Brand drugs: 202 claims; generic drugs: 273 claims; opioid claims: 11.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Carlos S Madamba $213 ($213 in general payments such as food, travel and fees) from 7 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $63.1.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.